Contact the Yasmin lawsuit attorneys of Williams Hart today - 800-761-3187.

FDA: Yaz, Yasmin has 75 percent higher risk of blood clot

Posted on November 2nd, 2011 No Comments

The Food and Drug Administration has conducted a study into the drospirenone-containing birth control pills, Yasmin and Yaz and found that these birth controls have a 75 percent higher risk of causing blood clots.

The report about the drug’s safety was released last week and stated that results from the study show that the birth control pill increases a woman’s risk of developing a blood clot. This study was released just weeks before the FDA will meet with a committee about Yasmin and Yaz.

The FDA’s study looked into 800,000 women between the years 2001 and 2007 and it found that the women who used the drospirenone-containing oral contraceptives faced a 75 percent higher risk of developing a blood clot and that symptoms were usually seen within three months of starting the pill.

If you or a loved one has developed a blood clot after using Yasmin or Yaz birth control, you need experienced representation on your side. Contact the Yasmin lawsuit  lawyers of Williams Hart by calling 800-761-3187 today.

Leave a Reply

Contact Williams Hart

By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.

Williams Hart Represents Yasmin/Yaz Victims Nationwide

Williams Hart represents clients across the country. Click here to learn more.

home  |  about us  |  attorneys  |  yaz  |  yasmin  |  ocella  |  faqs  |  articles  |  contact us  |  blog  |  Legal Colleagues  |  Log in
Copyright ©2007-2009 Williams Hart. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Hart's main office is located in Houston, Texas. Terms of Use. Disclaimer.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-761-3187

Search Engine Optimization provided by The Search Engine Guys.